Question 1

How many institutions own DFTX stock?

Accepted Answer

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own DFTX shares is N/A, representing N/A of the company's common stock.

Question 2

Who are the major shareholders selling Definium Therapeutics, Inc. stock?

Accepted Answer

N/A, in the last quarter, reduced its stake in DFTX by N/A restricting it's holding to - shares of worth nearly -. N/A also lessened N/A of the DFTX shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned DFTX shares holding by N/A last quarter which brought its holding to - shares worth -.

Question 3

Investors who are buying DFTX stock?

Accepted Answer

As per its latest 13F filing, N/A increased its stake in DFTX by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of DFTX to its portfolio, raising its holding to - shares of worth -. N/A also increased its DFTX shares holding by N/A which brought its holding to - shares worth -.

Question 4

DFTX's major insiders: who are they?

Accepted Answer

The insider with the most stakes in DFTX is Barrow Robert , Chief Executive Officer at the company. Additionally, DFTX stock is highly held by Chief Medical Officer Karlin Daniel and Chief Legal Officer Sullivan Mark among others.

Question 5

Did an insider recently sell DFTX stock?

Accepted Answer

Company executives, directors, and other insiders own N/A percent of Definium Therapeutics, Inc.'s stock. Within the last six months, there have been 3 transaction(s) in which DFTX insiders have sold stock, totaling 43.15K shares. Insiders that have sold shares include KARLIN DANIEL, SULLIVAN MARK, and BARROW ROBERT.

Question 6

Which insider recently purchased DFTX stock?

Accepted Answer

There have been 0 transaction(s) during the past 6-months in which Definium Therapeutics, Inc. insiders have bought stock, totalling 0 shares

Question 7

How much of DFTX does insiders own?

Accepted Answer

Around 1.44M Definium Therapeutics, Inc. shares are held by insiders, which represents about N/A of DFTX stock.

Question 8

Who is the insider with the largest stake?

Accepted Answer

DFTX Chief Executive Officer, Barrow Robert holds the largest portfolio of the company's shares. DFTX shares owned by Barrow total nearly 752.45 thousand.

Question 9

Which institution holds the most shares in DFTX?

Accepted Answer

N/A is the largest institutional owner in DFTX which holds - shares worth - or N/A of the total DFTX shares outstanding followed by N/A with ownership of - shares representing N/A of the DFTX ownership. N/A is the third largest stakeholder with - shares or N/A of the ownership worth more than -.

Question 10

Is Definium Therapeutics, Inc. stock optionable?

Accepted Answer

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the DFTX is concerned, it is a stock which is  optionable.

Question 11

Is there a short position on DFTX's shares?

Accepted Answer

Number of DFTX shares short is null. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

Question 12

About how many outstanding DFTX shares are there?

Accepted Answer

As of today, null shares of DFTX are outstanding.

Question 13

Is there many float in DFTX stock?

Accepted Answer

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, DFTX has null shares in float.

Question 14

DFTX short ratio: what is it?

Accepted Answer

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for DFTX is null.

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Mar 25, 2026	KARLIN DANIEL	SALE	18.47	8.02K	148.09K	413.32K
Mar 25, 2026	SULLIVAN MARK	SALE	18.47	10.7K	197.67K	271.08K
Mar 25, 2026	BARROW ROBERT	SALE	18.47	24.43K	451.24K	752.45K

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Mar 25, 2026	KARLIN DANIEL	SALE	18.47	8.02K	148.09K	413.32K
Mar 25, 2026	SULLIVAN MARK	SALE	18.47	10.7K	197.67K	271.08K
Mar 25, 2026	BARROW ROBERT	SALE	18.47	24.43K	451.24K	752.45K

DFTX Stock Ownership Breakdown

Definium Therapeutics

Stock Outstanding Shares

Institutional Ownership

Insiders

Buying/Selling by Insiders

Insider Transaction Summary (6 Months)

Frequently Asked Questions